Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18988990 | ULTRA-HIGH-CELL-DENSITY MULTICELLULAR TISSUE LIFTING BIOPRINTING DEVICE ASSISTED BY OBLIQUE INCIDENT BULK WAVE AND PRINTING METHOD THEREFOR | December 2024 | April 2025 | Allow | 4 | 0 | 0 | No | No |
| 18983137 | METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY | December 2024 | March 2025 | Allow | 3 | 1 | 0 | No | No |
| 18919051 | ANTIGEN BINDING POLYPEPTIDES | October 2024 | May 2025 | Abandon | 6 | 0 | 1 | Yes | No |
| 18885902 | COMPOSITION FOR REGULATING PRODUCTION OF FUSION PROTEINS | September 2024 | May 2025 | Allow | 8 | 1 | 0 | No | No |
| 18822374 | APPLICATION OF NANO LAYERED DOUBLE HYDROXIDE IN CARTILAGE REGENERATION AND PREPARATION THEREOF | September 2024 | April 2025 | Allow | 8 | 1 | 1 | No | No |
| 18817528 | CD34 STEM CELL MIMICS | August 2024 | June 2025 | Allow | 10 | 1 | 1 | No | No |
| 18784317 | COMPOSITION FOR REGULATING PRODUCTION OF PROTEINS | July 2024 | February 2025 | Allow | 6 | 1 | 0 | No | No |
| 18738959 | COMPOSITION FOR REGULATING PRODUCTION OF FUSION PROTEINS | June 2024 | January 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 18731209 | REAGENTS, REAGENT KITS, AND CULTURE MEDIA FOR ACTIVATING AND EXPANDING IMMUNE CELLS AND USES THEREOF | May 2024 | May 2025 | Allow | 12 | 2 | 1 | Yes | No |
| 18431132 | Egg Preparation in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection Platform | February 2024 | February 2025 | Allow | 13 | 1 | 1 | Yes | No |
| 18427711 | NON-TRANSGENE TRANSFECTION FOR THERAPEUTIC PURPOSES | January 2024 | June 2025 | Allow | 17 | 3 | 0 | Yes | No |
| 18419406 | METHODS FOR CHARACTERIZING CELL-FREE NUCLEIC ACID FRAGMENTS | January 2024 | July 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18414374 | CHEMOPREDICTIVE ASSAY FOR RECURRENT CHEMOTHERAPY | January 2024 | March 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18405995 | CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE | January 2024 | May 2025 | Allow | 17 | 2 | 0 | Yes | No |
| 18567880 | ISOLATED CELL MEMBRANE POTENTIAL DETECTION SYSTEM AND METHOD BASED ON MULTI-SPECTRAL MULTI-PARAMETER PHOTOSTIMULATION | December 2023 | November 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18524212 | PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED CD163 GENES | November 2023 | October 2024 | Allow | 11 | 2 | 0 | Yes | No |
| 18505026 | PERSONALIZED METHODS FOR DETECTING CIRCULATING TUMOR DNA | November 2023 | August 2024 | Allow | 9 | 3 | 0 | Yes | No |
| 18497415 | SPATIAL TRANSCRIPTOMICS FOR ANTIGEN-RECEPTORS | October 2023 | July 2024 | Allow | 9 | 2 | 0 | No | No |
| 18490030 | PAPN MUTANT AND COMPOSITION FOR SITE-DIRECTED MODIFICATION OF PAPN GENE AND APPLICATION THEREOF | October 2023 | January 2025 | Allow | 15 | 2 | 1 | No | No |
| 18485458 | ACELLULAR COMPOSITIONS AND METHODS | October 2023 | March 2025 | Abandon | 17 | 1 | 0 | No | No |
| 18481950 | DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETS | October 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18375868 | LYMPHOCYTE TARGETED LENTIVIRAL VECTORS | October 2023 | April 2024 | Allow | 7 | 2 | 0 | Yes | No |
| 18474506 | Cross-Species Compatible Adeno-Associated Virus Compositions and Methods of Use Thereof | September 2023 | July 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18471447 | CHEMICAL COMPOSITIONS AND METHODS OF USING SAME | September 2023 | April 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18370826 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | September 2023 | May 2024 | Abandon | 8 | 1 | 1 | No | No |
| 18470189 | SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF | September 2023 | September 2024 | Allow | 12 | 2 | 1 | Yes | No |
| 18275591 | TARGETED EXTRACELLULAR VESICLES FOR DELIVERY OF THERAPEUTICS | August 2023 | October 2024 | Allow | 15 | 1 | 0 | No | No |
| 18359013 | HIGH-TRANSDUCING HSV VECTORS | July 2023 | December 2024 | Allow | 16 | 1 | 0 | No | No |
| 18351689 | ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS | July 2023 | November 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 18351800 | ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS | July 2023 | November 2024 | Allow | 17 | 2 | 0 | Yes | No |
| 18351674 | ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS | July 2023 | November 2024 | Allow | 16 | 4 | 0 | Yes | No |
| 18351651 | PLASMID TARGET, PRIMER PROBE, KIT AND METHOD FOR DETECTING RESIDUAL HOST DNA IN CELLULAR OR VIRAL FORMULATION | July 2023 | September 2024 | Abandon | 14 | 1 | 1 | Yes | No |
| 18221026 | SYSTEMS AND METHODS FOR PRODUCING INJECTABLE ENHANCED STEM CELL EXOSOMES, IMPROVED EXOSOMES AND METHODS OF USE | July 2023 | March 2025 | Allow | 20 | 4 | 1 | Yes | No |
| 18351345 | METHOD FOR FORMING A POROUS CELL SUBSTRATE | July 2023 | October 2024 | Allow | 15 | 2 | 1 | Yes | No |
| 18217310 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | June 2023 | March 2024 | Abandon | 9 | 1 | 0 | No | No |
| 18344732 | HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | June 2023 | April 2025 | Allow | 21 | 1 | 1 | Yes | No |
| 18259177 | Nanopatterned Films with Patterned Surface Chemistry | June 2023 | June 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18340501 | METHODS, COMPOSITIONS, AND SYSTEMS FOR CAPTURING ANALYTES FROM GLIOBLASTOMA SAMPLES | June 2023 | June 2024 | Abandon | 12 | 1 | 1 | No | No |
| 18336901 | METHODS FOR CHARACTERIZING CELL-FREE NUCLEIC ACID FRAGMENTS | June 2023 | January 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18322531 | METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF | May 2023 | January 2024 | Allow | 8 | 2 | 0 | No | No |
| 18199013 | NANOBARCODE FOR CONTROLLING CELL ADHESION AND DIFFERENTIATION OF STEM CELLS, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND DIFFERENTIATION OF STEM CELLS BY USING THE SAME | May 2023 | February 2025 | Allow | 21 | 1 | 0 | Yes | No |
| 18317841 | MICRONEEDLE DEVICES AND METHODS, AND SKIN CONDITION ASSAYS | May 2023 | September 2024 | Abandon | 16 | 1 | 1 | No | No |
| 18316899 | VIRAL VECTORS FOR CANCER THERAPY | May 2023 | May 2025 | Allow | 24 | 3 | 0 | Yes | No |
| 18315289 | SPATIAL TRANSCRIPTOMICS FOR ANTIGEN-RECEPTORS | May 2023 | October 2023 | Allow | 5 | 1 | 0 | No | No |
| 18141534 | MOLECULAR WIRES FOR DETECTING A BIOLOGICAL OR CHEMICAL ENTITY OR EVENT | May 2023 | December 2023 | Allow | 7 | 1 | 0 | No | No |
| 18306518 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER | April 2023 | December 2023 | Abandon | 8 | 1 | 0 | No | No |
| 18138361 | TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES | April 2023 | June 2025 | Abandon | 25 | 1 | 1 | No | No |
| 18129357 | METHODS AND SYSTEMS FOR DETERMINING SPATIAL PATTERNS OF BIOLOGICAL TARGETS IN A SAMPLE | March 2023 | September 2023 | Allow | 6 | 1 | 0 | No | No |
| 18192107 | MOLECULAR MARKER FOR GENETIC RESISTANCE OF CHICKEN TO INFECTION BY SUBGROUPS A AND K AVIAN LEUKOSIS VIRUS AND USE THEREOF | March 2023 | July 2024 | Abandon | 15 | 1 | 0 | Yes | No |
| 18188755 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | March 2023 | January 2024 | Allow | 10 | 1 | 1 | No | No |
| 18187578 | MOLECULE COUNTING OF METHYLATED CELL-FREE DNA FOR TREATMENT MONITORING | March 2023 | January 2024 | Allow | 10 | 2 | 0 | Yes | No |
| 18185118 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | March 2023 | October 2023 | Allow | 7 | 1 | 0 | No | No |
| 18184615 | METHOD AND APPARATUS FOR RAPID ANALYSIS OF A BIOLOGICAL SAMPLE | March 2023 | February 2024 | Allow | 11 | 1 | 0 | No | No |
| 18120059 | KIT, DEVICE, AND METHOD FOR DETECTING LUNG CANCER | March 2023 | March 2024 | Allow | 12 | 0 | 1 | Yes | No |
| 18179684 | CHEMICAL COMPOSITIONS AND METHODS OF USING SAME | March 2023 | September 2023 | Allow | 7 | 1 | 1 | No | No |
| 18179945 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | March 2023 | November 2023 | Allow | 8 | 2 | 0 | No | No |
| 18179924 | AFFINITY REAGENTS HAVING ENHANCED BINDING AND DETECTION CHARACTERISTICS | March 2023 | March 2024 | Allow | 13 | 1 | 0 | No | No |
| 18179961 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | March 2023 | October 2023 | Allow | 8 | 2 | 0 | No | No |
| 18179795 | SPATIAL ANALYSIS TO DETECT SEQUENCE VARIANTS | March 2023 | December 2023 | Allow | 9 | 1 | 0 | Yes | No |
| 18023739 | DETECTION KIT FOR SALMONELLA TYPHI , PREPARATION METHOD AND APPLICATION THEREOF | February 2023 | July 2024 | Allow | 16 | 1 | 1 | Yes | No |
| 18176360 | DETECTION AND TREATMENT OF AUTISM SPECTRUM DISORDERS | February 2023 | August 2024 | Abandon | 18 | 1 | 0 | No | No |
| 18112116 | COMPOSITIONS AND METHODS FOR DETERMINING ENDOMETRIAL CANCER PROGNOSIS | February 2023 | July 2024 | Abandon | 16 | 0 | 1 | No | No |
| 18168517 | DIAGNOSIS OF SEPSIS | February 2023 | August 2024 | Abandon | 18 | 0 | 1 | No | No |
| 18108699 | FIBROUS BIRTH TISSUE COMPOSITION AND METHOD OF USE | February 2023 | April 2025 | Allow | 26 | 1 | 1 | No | No |
| 18166447 | METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY | February 2023 | November 2024 | Allow | 22 | 3 | 0 | Yes | No |
| 18105745 | METHYLATION MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND LUNG CANCER | February 2023 | August 2024 | Abandon | 19 | 1 | 1 | No | No |
| 18100437 | METHODS OF PREPARING A PRIMARY CELL SAMPLE | January 2023 | September 2024 | Allow | 20 | 1 | 0 | No | No |
| 18100301 | CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS | January 2023 | August 2024 | Abandon | 19 | 1 | 0 | No | No |
| 18100133 | METHODS FOR SPATIAL ANALYSIS USING RNA-TEMPLATED LIGATION | January 2023 | October 2023 | Allow | 8 | 1 | 0 | Yes | No |
| 18151794 | Spatially Encoded Biological Assays | January 2023 | August 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18148350 | NEXT-GENERATION SEQUENCING FOR PROTEIN MEASUREMENT | December 2022 | December 2023 | Allow | 12 | 1 | 0 | No | No |
| 18087724 | METHODS AND SYSTEMS TO IMPROVE THE SIGNAL TO NOISE RATIO OF DNA METHYLATION PARTITIONING ASSAYS | December 2022 | January 2024 | Allow | 13 | 2 | 1 | Yes | No |
| 18085217 | DETECTION AND DIGITAL QUANTITATION OF MULTIPLE TARGETS | December 2022 | August 2023 | Allow | 8 | 1 | 0 | No | No |
| 18084115 | METHODS AND KITS FOR EVALUATING ZINC LEVELS IN MILK | December 2022 | July 2024 | Abandon | 19 | 2 | 1 | No | No |
| 18008674 | ARTIFICIAL NON-CODING RNA MODULE FOR ENHANCING NITROGEN FIXATION ABILITY OF MICROORGANISMS | December 2022 | January 2025 | Allow | 25 | 2 | 0 | Yes | No |
| 18074992 | Spatially Encoded Biological Assays | December 2022 | July 2023 | Allow | 7 | 1 | 0 | No | No |
| 18062011 | METHODS OF MECHANICAL MICROFLUIDIC MANIPULATION | December 2022 | May 2023 | Allow | 5 | 0 | 0 | No | No |
| 17990164 | ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | November 2022 | February 2024 | Allow | 15 | 0 | 0 | No | No |
| 17988959 | KIT, DEVICE AND METHOD FOR DETECTING PROSTATE CANCER | November 2022 | November 2023 | Allow | 11 | 1 | 0 | No | No |
| 18053035 | BIOMARKER FOR PREDICTING AGE IN DAYS OF PIGS, AND PREDICTION METHOD | November 2022 | May 2024 | Abandon | 18 | 1 | 1 | No | No |
| 18052082 | OPTIMIZED CLN1 GENES AND EXPRESSION CASSETTES AND THEIR USE | November 2022 | November 2024 | Allow | 25 | 1 | 0 | No | No |
| 17977451 | PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | October 2022 | December 2023 | Allow | 13 | 1 | 0 | No | No |
| 17977377 | LUNG CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | October 2022 | October 2023 | Allow | 11 | 1 | 0 | No | No |
| 17974226 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | October 2022 | July 2023 | Allow | 9 | 1 | 0 | No | No |
| 17974395 | METHOD AND COMPOSITION FOR HYPOTHERMIC STORAGE OF PLACENTAL TISSUE | October 2022 | August 2024 | Allow | 22 | 1 | 0 | No | No |
| 18049094 | IMAGING SYSTEM HARDWARE | October 2022 | January 2024 | Abandon | 14 | 1 | 0 | No | No |
| 18048512 | SYSTEM AND METHOD FOR LEAKAGE CONTROL IN A PARTICLE CAPTURE SYSTEM | October 2022 | August 2023 | Allow | 10 | 2 | 0 | Yes | No |
| 17970824 | LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | October 2022 | July 2023 | Allow | 9 | 0 | 0 | No | No |
| 17967250 | METHODS OF PREPARING PERSONALIZED BLOOD VESSELS | October 2022 | April 2025 | Allow | 30 | 1 | 1 | No | No |
| 18045942 | DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING | October 2022 | January 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18045711 | COMPOSITION AND REAGENT KIT FOR EARLY DETECTION OF CERVICAL HIGH-GRADE LESIONS AND CERVICAL CANCER | October 2022 | September 2023 | Allow | 11 | 1 | 0 | No | No |
| 13816709 | Compositions and Methods for Quantifying a Nucleic Acid Sequence in a Sample | October 2022 | April 2022 | Allow | 60 | 10 | 1 | Yes | No |
| 17957579 | Control of Copolymer Compositions | September 2022 | March 2025 | Abandon | 29 | 1 | 1 | No | No |
| 17936023 | D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF | September 2022 | June 2025 | Allow | 33 | 0 | 0 | No | No |
| 17936335 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | September 2022 | February 2023 | Allow | 5 | 1 | 0 | No | No |
| 17907138 | CONTROLS FOR PROXIMITY DETECTION ASSAYS | September 2022 | August 2024 | Abandon | 23 | 2 | 0 | Yes | No |
| 17948560 | STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | September 2022 | September 2023 | Allow | 12 | 1 | 0 | No | No |
| 17946613 | GENETIC TESTING FOR INHERITED PERIPHERAL NEUROPATHY | September 2022 | May 2024 | Allow | 20 | 2 | 1 | Yes | No |
| 17932574 | DETECTION OF LUNG NEOPLASIA BY AMPLIFICATION OF RNA SEQUENCES | September 2022 | May 2024 | Allow | 20 | 1 | 1 | Yes | No |
| 17944779 | BREAST CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD | September 2022 | August 2023 | Allow | 11 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1634.
With a 31.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 15.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Art Unit 1634 is part of Group 1630 in Technology Center 1600. This art unit has examined 15,611 patent applications in our dataset, with an overall allowance rate of 39.0%. Applications typically reach final disposition in approximately 37 months.
Art Unit 1634's allowance rate of 39.0% places it in the 2% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.
Applications in Art Unit 1634 receive an average of 2.15 office actions before reaching final disposition (in the 76% percentile). The median prosecution time is 37 months (in the 13% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.